Journal
PEDIATRIC CLINICS OF NORTH AMERICA
Volume 66, Issue 5, Pages 925-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.pcl.2019.06.001
Keywords
Severe asthma; Asthma endotypes; Biologics; Long-acting antimuscarinic agents; Bronchial thermoplasty
Categories
Ask authors/readers for more resources
Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
